Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
635 studies found for:    osteoporosis AND (woman OR women OR female)
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Evaluation of an Osteoporosis Prevention Strategy in Women With Osteoporotic Fracture of the Upper Limb
Condition: Osteoporosis With Current Fragility Fracture
Intervention: Behavioral: Osteoporosis prevention program
2 Completed TOP: Trial of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
Condition: Osteoporosis
Intervention: Drug: ALX1-11
3 Completed The Effect of a Short Educational Program on Young Women's Knowledge and Beliefs About Osteoporosis
Condition: Osteoporosis
Intervention: Behavioral: Education
4 Recruiting Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women
Condition: Adult Idiopathic Generalized Osteoporosis
Interventions: Drug: Teriparatide;   Drug: Saline Placebo
5 Completed Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Post-Menopausal
Intervention: Drug: teriparatide
6 Completed Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: Raloxifene HCL;   Drug: Placebo
7 Completed Optimal Management of Women With Wrist Fractures
Conditions: Osteoporosis;   Osteopenia
Intervention: Procedure: Educational Material and Reminder
8 Completed
Has Results
Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
Condition: Osteoporosis
Interventions: Drug: Bazedoxifene Acetate;   Other: Placebo
9 Completed A Study of the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Post-Menopausal
Interventions: Drug: teriparatide 20 micrograms/day subcutaneous;   Drug: salmon calcitonin 100 IU/day subcutaneous
10 Completed Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: teriparatide 20 micrograms/day subcutaneous;   Drug: salmon calcitonin 100 IU/day subcutaneous
11 Active, not recruiting Oklahoma Native American Women's Osteoporosis Screening Study
Condition: Osteoporosis
Intervention:
12 Not yet recruiting Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday
Condition: Osteoporosis
Intervention: Other: Questionnaires about compliance and persistence with bisphosphonates treatment
13 Unknown  Recognizing Osteoporosis and Its Consequences in Quebec (ROCQ) Programme
Condition: Osteoporosis
Interventions: Behavioral: Control Group;   Behavioral: Written documentation on osteoporosis group;   Behavioral: Written documentation on osteoporosis and video group
14 Completed Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: teriparatide;   Drug: Placebo;   Drug: Calcium Supplement;   Drug: Vitamin D Supplement
15 Active, not recruiting Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women
Conditions: Premenopause;   Low Bone Density;   Fracture;   Osteoporosis
Intervention: Drug: Teriparatide (PTH 1-34)
16 Active, not recruiting A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Denosumab (CP2);   Drug: Denosumab (CP4)
17 Enrolling by invitation Point-of-care Osteoporosis Diagnostics With Bindex® Pocket Size Instrument and FRAX
Condition: Osteoporosis
Intervention:
18 Completed Safety and Efficacy of Whole-body Vibration as add-on Treatment of Osteoporosis in Post-menopausal Women
Condition: Osteoporosis in Post-menopausal Women
Intervention: Device: Whole body vibration
19 Completed Post-menopausal Women Osteoporosis(Phase III)
Condition: Postmenopausal Women Osteoporosis
Interventions: Drug: risedronate combine;   Drug: Risedronate;   Drug: Placebo(for Risedronate);   Drug: Placebo(for risedronate combine)
20 Recruiting Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Postmenopausal Women With Osteoporosis
Interventions: Drug: Romosozumab;   Drug: Alendronate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years